Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Protara Therapeutics (TARA) Preferred Dividend Payments (2017)

Protara Therapeutics' Preferred Dividend Payments history spans 3 years, with the latest figure at $6.7 million for Q3 2017.

  • Quarterly Preferred Dividend Payments changed N/A to $6.7 million in Q3 2017 from the year-ago period, while the trailing twelve-month figure was $18.4 million through Sep 2017, changed N/A year-over-year, with the annual reading at $6.4 million for FY2014, 3.82% up from the prior year.
  • Preferred Dividend Payments came in at $6.7 million for Q3 2017, down from $12.0 million in the prior quarter.
  • In the past five years, Preferred Dividend Payments ranged from a high of $12.0 million in Q4 2014 to a low of -$2.3 million in Q3 2014.
  • The 3-year median for Preferred Dividend Payments is $1.5 million (2013), against an average of $3.3 million.
  • The largest YoY upside for Preferred Dividend Payments was 681.75% in 2014 against a maximum downside of 247.86% in 2014.
  • Protara Therapeutics' Preferred Dividend Payments stood at $1.5 million in 2013, then skyrocketed by 681.75% to $12.0 million in 2014, then crashed by 43.96% to $6.7 million in 2017.
  • Per Business Quant, the three most recent readings for TARA's Preferred Dividend Payments are $6.7 million (Q3 2017), $12.0 million (Q4 2014), and -$2.3 million (Q3 2014).